A Synopsis Of Themis Medicare Viralex
Mumbai-based pharmaceutical company Themis Medicare?s anti-viral drug Viralex has received Drugs Controller General of India?s (DCGI) approval, the company informed the stock exchange on Monday
Drug Approval | 21/03/2022 | By Darshana | 403
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy